IGF1 and esophageal adenocarcinoma: Serum IGF-1 levels in the highest tertile were associated with an increased risk of Barrett's esophagus (adjusted OR 4.05, 95% CI 2.01–8.17) compared with a control group who underwent screening colonoscopy, but were not significantly different from a control group of subjects with GERD [92].